American Academy of Neurology Annual Meeting (AAN)TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum By admin / 02/18/2025
American Academy of Neurology Annual Meeting (AAN)MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide By Sheena Cruz / 11/25/2024
